Anifrolumab Early Access Program

NCT04750057 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Anifrolumab

Sponsor

AstraZeneca

Collaborators

[object Object]